<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF InhibitorsFei Su, Jeffrey A. Sosman, Paul B. Chapman et al.|New England Journal of Medicine|2012Cited by 1k
Stromal lipid species dictate melanoma metastasis and tropismShilpa Gurung, Amaya Virós, Timothy Budden et al.|Cancer Cell|2025Cited by 29
The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancersG. Saturno, Caroline J. Springer, Filipa M. Lopes et al.|Annals of Oncology|2020Cited by 21
Female immunity protects from cutaneous squamous cell carcinomaTimothy Budden, Amaya Virós|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 5
Systemic immunosuppression from ultraviolet radiation exposure inhibits cancer immunotherapyPedro Durao, Amaya Virós|Journal for ImmunoTherapy of Cancer|2025Cited by 0